CABIO(SH:688089)2023-04-27 16:00Financial Performance - The company's operating revenue for Q1 2023 was CNY 87,762,301.30, representing a year-on-year increase of 16.18%[5]. - Net profit attributable to shareholders decreased by 38.40% year-on-year, amounting to CNY 14,307,104.28[5][9]. - The net profit after deducting non-recurring gains and losses fell by 47.96%, totaling CNY 7,302,325.16[5][9]. - The net profit for Q1 2023 was CNY 13,529,876.56, a decrease of 38.5% compared to CNY 22,013,486.90 in Q1 2022[20]. - Operating profit for Q1 2023 was CNY 11,084,400.27, down 43.4% from CNY 19,512,167.40 in the same period last year[20]. - The total comprehensive income for Q1 2023 was CNY 13,529,876.56, compared to CNY 21,533,439.04 in Q1 2022[21]. - Basic and diluted earnings per share were both CNY 0.12, reflecting a decrease of 37.25% year-on-year[6][9]. - Basic and diluted earnings per share for Q1 2023 were both CNY 0.12, down from CNY 0.19 in the same quarter last year[21]. Cash Flow - The net cash flow from operating activities was negative at CNY -5,286,511.48, a decline of 108.22% compared to the previous year[6][9]. - Cash flow from operating activities turned negative at CNY -5,286,511.48, compared to a positive CNY 64,335,059.13 in Q1 2022[24]. - The company reported a net cash outflow from investing activities of CNY -108,285,178.74, an improvement from CNY -187,471,146.88 in Q1 2022[24]. - The total cash inflow from investment activities was CNY 161,357,266.04, a decrease of 50.0% compared to CNY 323,026,382.45 in Q1 2022[34]. - The net cash flow from investment activities was -CNY 111,127,175.72, an improvement from -CNY 189,490,113.90 in Q1 2022[34]. - Cash and cash equivalents at the end of Q1 2023 were CNY 361,033,982.93, down from CNY 529,569,351.18 at the end of Q1 2022[34]. - The cash outflow for purchasing goods and services increased to CNY 76,920,055.38, up 105.0% from CNY 37,475,015.22 in Q1 2022[32]. - The company did not report any cash inflow from financing activities in Q1 2023[34]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,592,109,549.99, a decrease of 1.16% from the end of the previous year[6]. - Total assets as of March 31, 2023, amounted to RMB 1,592,109,549.99, a slight decrease from RMB 1,610,828,359.79 at the end of 2022[15]. - Total liabilities decreased to RMB 150,553,704.96 from RMB 185,767,562.26, indicating a reduction of 19%[16]. - The company's total liabilities decreased to CNY 199,235,766.86 in Q1 2023 from CNY 234,618,597.19 in Q4 2022, a reduction of approximately 15.1%[28]. - Shareholders' equity increased to RMB 1,441,555,845.03 from RMB 1,425,060,797.53, showing a growth of 1.2%[16]. - The company's total equity increased to CNY 1,461,999,276.93 in Q1 2023 from CNY 1,444,628,761.79 in Q4 2022, showing a growth of 1.2%[28]. Research and Development - Research and development expenses totaled CNY 7,517,071.87, which is 8.57% of operating revenue, an increase of 0.46 percentage points year-on-year[6]. - Research and development expenses increased to CNY 7,517,071.87, up 22.8% from CNY 6,121,712.21 in the previous year[20]. - Research and development expenses increased to CNY 6,578,632.54 in Q1 2023, up from CNY 5,491,702.14 in Q1 2022, indicating a growth of 19.8%[30]. Inventory and Accounts Payable - Inventory levels rose to RMB 115,581,174.69, up from RMB 81,490,915.63, marking an increase of 42%[14]. - The company reported a decrease in accounts payable to RMB 86,224,694.99 from RMB 107,335,303.41, a decline of 19.7%[15]. - The company's inventory increased to CNY 110,586,346.86 in Q1 2023 from CNY 78,443,729.20 in Q1 2022, reflecting a growth of 41.0%[27]. Market Strategy - The company is focused on expanding its market presence and developing new technologies, although specific details were not disclosed in the report[13].